Silence Therapeutics Ownership | Who Owns Silence Therapeutics?
Silence Therapeutics Ownership Summary
Silence Therapeutics is owned by 15.47% institutional investors, 23.23% insiders, and 61.30% retail investors. Artal group is the largest institutional shareholder, holding 6.32% of SLN shares. Eventide Healthcare & Life Sciences I is the top mutual fund, with 1.36% of its assets in Silence Therapeutics shares.
SLN Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Silence Therapeutics | 15.47% | 23.23% | 61.30% |
| Sector | Healthcare Stocks | 279.18% | 10.62% | -189.80% |
| Industry | Biotech Stocks | 63.96% | 10.74% | 25.30% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Artal group | 2.78M | 6.32% | $52.81M |
| Lombard odier asset management (usa) | 2.41M | 5.47% | $36.76M |
| Frazier life sciences management | 1.15M | 2.61% | $21.82M |
| Tcg crossover management | 3.03M | 2.16% | $20.87M |
| Siren | 2.83M | 2.02% | $19.48M |
| Redmile group | 2.40M | 1.71% | $16.51M |
| Vivo capital | 1.11M | 0.79% | $7.61M |
| Sg americas securities | 343.20K | 0.78% | $6.52M |
| Nantahala capital management | 1.05M | 0.75% | $7.22M |
| Morgan stanley | 303.99K | 0.69% | $5.78M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Lombard odier asset management (usa) | 2.41M | 2.72% | $36.76M |
| Tcg crossover management | 3.03M | 2.04% | $20.87M |
| Artal group | 2.78M | 1.35% | $52.81M |
| M28 capital management lp | 185.10K | 1.25% | $1.27M |
| Redmile group | 2.40M | 1.15% | $16.51M |
| Saturn v capital management | 395.02K | 1.06% | $2.72M |
| Nextech invest | 952.40K | 1.06% | $6.55M |
| Frazier life sciences management | 1.15M | 1.02% | $21.82M |
| Siren | 2.83M | 0.86% | $19.48M |
| Vivo capital | 1.11M | 0.85% | $7.61M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Nantahala capital management | 1.05M | 0.31% | 849.68K |
| Redmile group | 2.40M | 1.15% | 500.00K |
| Sg americas securities | 343.20K | 0.04% | 336.20K |
| Marshall wace, llp | 488.89K | 0.00% | 320.47K |
| Ubs group | 356.07K | 0.00% | 285.41K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Lombard odier asset management (europe) | - | - | -2.24M |
| Janus henderson group | - | - | -1.09M |
| Polar capital | - | - | -1.00M |
| Deep track capital, lp | - | - | -1.00M |
| Eventide asset management | - | - | -640.00K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Blackrock funding, inc. /de | 211.51K | - | 211.51K | $1.46M |
| Acadian asset management | 19.47K | 0.00% | 19.47K | $133.00K |
| Fny investment advisers | 17.52K | 0.06% | 17.52K | $120.00K |
| China universal asset management | 9.96K | 0.01% | 9.96K | $68.55K |
| Jpmorgan chase | 3.79K | - | 3.79K | $26.10K |
Sold Out
| Holder | Change |
|---|---|
| Lazard asset management | -60.00 |
| Values first advisors | -3.09K |
| Advisors preferred | -5.32K |
| Quarry lp | -6.00K |
| Vestcor | -8.80K |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2025 | 60 | -9.09% | 21,913,755 | -11.60% | 15 | 4.95% | 23 | -39.47% | 25 | 92.31% |
| Dec 31, 2024 | 61 | -14.08% | 21,582,466 | -23.46% | 15 | 0.42% | 35 | -5.41% | 12 | -20.00% |
| Sep 30, 2024 | 70 | - | 28,105,051 | 3.61% | 60 | 1.79% | 37 | 12.12% | 14 | -26.32% |
| Jun 30, 2024 | 69 | 9.52% | 27,125,546 | -1.84% | 61 | 1.11% | 33 | -31.25% | 18 | 63.64% |
| Mar 31, 2024 | 63 | 85.29% | 27,634,707 | 34.54% | 74 | 2.46% | 48 | 182.35% | 11 | 83.33% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Eventide Healthcare & Life Sciences I | 640.00K | 1.36% | - |
| International Biotechnology Ord | 601.48K | 1.27% | - |
| Polar Capital Biotech S Inc | 467.15K | 0.99% | -532.85K |
| MEDICAL BioHealth EUR Acc | 295.00K | 0.62% | - |
| iShares Biotechnology ETF | 167.65K | 0.35% | -2.19K |
| T. Rowe Price Health Sciences | 95.65K | 0.20% | 95.65K |
| BIT Biotech Opportunities S | 92.43K | 0.20% | -14.87K |
| Tema Obesity & Cardiometabolic ETF | 76.77K | 0.16% | - |
| Galileo - Biotech Innovation Fund S USD | 58.65K | 0.12% | - |
| Aesculape SRI IC | 47.00K | 0.10% | 47.00K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| May 26, 2025 | Griffiths Richard Ian | - | Buy | $130.94K |
| May 27, 2025 | Griffiths Richard Ian | - | Buy | $256.50K |
| May 28, 2025 | Griffiths Richard Ian | - | Buy | $46.85K |
| May 22, 2025 | Griffiths Richard Ian | - | Buy | $96.64K |
| May 23, 2025 | Griffiths Richard Ian | - | Buy | $84.56K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q2 | 28 | - |
| 2025 Q1 | 13 | - |
SLN Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools